940
Views
3
CrossRef citations to date
0
Altmetric
Review Article

Four and five dimensional radiotherapy with reference to prostate cancer – definitions, state of the art and further directions – an overview

, , &
Pages 104-110 | Received 14 Aug 2010, Accepted 28 Sep 2010, Published online: 23 May 2011

References

  • Adolfsson J. Screening for prostate cancer – will we ever know? Acta Oncol 2010;49:275–7.
  • Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, . Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): An open randomised phase III trial. Lancet 2009;373(9660):301–8.
  • Bolla M, van Poppel H, Collette L, van Cangh P, Vekemans K, Da Pozzo L, . Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911). Lancet 2005;366(9485):572–8.
  • Gatta G, Zigon G, Buemi A, Coebergh JW, Colonna M, Contiero P, . Prostate cancer treatment in Europe at the end of 1990s. Acta Oncol 2009;48:867–73.
  • Suit H. The Gray Lecture 2001: Coming technical advances in radiation oncology. Int J Radiat Oncol Biol Phys 2002; 53:798–809.
  • Landberg T. Progress in radiotherapy. Acta Oncol 1995;34: 1023–9.
  • Ikushima H. Radiation therapy: State of the art and the future. J Med Invest. 2010;57:1–11.
  • Gottlieb KL, Hansen CR, Hansen O, Westberg J, Brink C. Investigation of respiration induced intra- and inter-fractional tumour motion using a standard Cone Beam CT. Acta Oncol 2010;49:1192–8.
  • van Dam IE, van Sörnsen de Koste JR, Hanna GG, Muirhead R, Slotman BJ, Senan S. Improving target delineation on 4-dimensional CT scans in stage I NSCLC using a deformable registration tool. Radiother Oncol 2010;96:67–72.
  • Levitt SH, Perez CA, Hui S, Purdy JA. Evolution of computerized radiotherapy in radiation oncology: Potential problems and solutions. Int J Radiat Oncol Biol Phys 2008;70: 978–86.
  • Keall P.4-dimensional computed tomography imaging and treatment planning. Semin Radiat Oncol 2004;14:81–90.
  • Bucci MK, Bevan A, Roach M 3rd. Advances in radiation therapy: Conventional to 3D, to IMRT, to 4D, and beyond. CA Cancer J Clin 2005;55:117–34.
  • Isacsson U, Nilsson K, Asplund S, Morhed E, Montelius A, Turesson I. A method to separate the rectum from the prostate during proton beam radiotherapy of prostate cancer patients. Acta Oncol 2010;49:500–5.
  • Lennernäs B, Letocha H, Rikner G, Magnusson A, Nilsson S. Field displacement during external radiotherapy in prostatic adenocarcinoma treated with radioactive 198Au implants and external irradiation. Acta Oncol 1995; 34:959–64.
  • Poulsen PR, Cho B, Sawant A, Ruan D, Keall PJ. Dynamic MLC tracking of moving targets with a single kV imager for 3D conformal and IMRT treatments. Acta Oncol 2010;49: 1092–100.
  • Johansen S, Cozzi L, Olsen DR. A planning comparison of dose patterns in organs at risk and predicted risk for radiation induced malignancy in the contralateral breast following radiation therapy of primary breast using conventional, IMRT and volumetric modulated arc treatment techniques. Acta Oncol 2009;48:495–503.
  • Hall EJ, Wuu CS. Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003;56:83–8.
  • Kindblom J, Ekelund-Olvenmark AM, Syren H, Iustin R, Braide K, Frank-Lissbrant I, . High precision transponder localization using a novel electromagnetic positioning system in patients with localized prostate cancer. Radiother Oncol 2009;90:307–11.
  • Strandqvist M. Studien iiber die kumulative Wirkung der Rontgenstrahlen bei Fraktionierung. Erfahrungen aus dem Radiumhemmet an 280 Haut- und Lippenkarzinomen. German. Acta Radiol 1944;(Suppl 55):1–300.
  • Fowler JF. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol 2005;44: 265–76.
  • Adami HO. The prostate cancer pseudo-epidemic. Acta Oncol. 2010;49:298–304.
  • Gao M, Mayr NA, Huang Z, Zhang H, Wang JZ. When tumor repopulation starts? The onset time of prostate cancer during radiation therapy. Acta Oncol 2010.
  • Thames HD, Kuban D, Levy LB, Horwitz EM, Kupelian P, Martinez A, . The role of overall treatment time in the outcome of radiotherapy of prostate cancer: An analysis of biochemical failure in 4839 men treated between 1987 and 1995. Radiother Oncol 2010;96:6–12. Epub 2010 Apr 17.
  • Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB, . Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An introduction to the scientific issues. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S3–9.
  • Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, . Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S10–9.
  • Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO. Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S123–9.
  • Liu M, Moiseenko V, Agranovich A, Karvat A, Kwan W, Saleh ZH, . Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model. Acta Oncol 2010;49:1040–4.
  • Stensvold A, Dahl AA, Fosså SD, Axcrona K, Lilleby W, Brennhovd B, . Clinicians’ use of guidelines as illustrated by curative treatment of prostate cancer at a comprehensive cancer center. Acta Oncol 2010;50:408–14.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.